Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis

Apr-24

Diabetes

AUTHORS : Ippazio Cosimo Antonazzo, Research Centre on Public Health (CESP), University of Milano-Bicocca, ippazio.antonazzo@unimib.it

JOURNAL : Acta Diabetologica

REFERENCE:

DOI : 10.1007/s00592-024-02276-3

Read more